ATOVAQUONE/PROGUANIL ZENTIVA 62.5 mg/25 mg for children, film-coated tablet 12 tablets
Active ingredients: Atovaquone, Proguanil hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATOVAQUONE/PROGUANIL ZENTIVA 62,5 mg/25 mg ENFANTS, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium papier de 12 comprimé(s) avec sécurité enfant
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Nov 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62902865CIP72748978CIP133400927489785Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATOVAQUONEcomprimé | 62,5 mg · un comprimé | SA |
| CHLORHYDRATE DE PROGUANILcomprimé | 25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.